Nexalin Technology (NXL) Other Working Capital Changes (2022)
Nexalin Technology's (NXL) quarterly Other Working Capital Changes came in at -$4463.0 in Q1 2024, up 63.52% year-on-year from -$2729.3 in Q2 2023, and up 66.12% quarter-over-quarter from -$13172.0 in Q4 2023.
Nexalin Technology (NXL) Other Working Capital Changes (2022) Analysis & Trends
Nexalin Technology's Other Working Capital Changes history runs 1 years deep, the most recent figure standing at -$260000.0 for Q3 2022.
- On a quarterly basis, Other Working Capital Changes rose 63.52% year-over-year to -$4463.0 in Q1 2024; TTM through Dec 2024 was -$4463.0, a 91.21% increase from a year earlier, with the FY2024 full-year figure at -$4463.0, up 91.21% from the prior year.
- Other Working Capital Changes climbed to -$4463.0 in Q1 2024 per NXL's latest filing, from -$13172.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at -$4463.0 in Q1 2024 and bottomed at -$13172.0 in Q4 2023.
- The 4-year median for Other Working Capital Changes is -$11791.5 (2022), against an average of -$11088.4.
- Across the five-year window, Other Working Capital Changes dropped 24.45% in 2022 and soared 63.52% in 2024, its largest moves.
- Year by year, Other Working Capital Changes stood at -$9591.0 in 2021, then declined by 24.45% to -$11936.0 in 2022, then declined by 10.36% to -$13172.0 in 2023, then soared by 66.12% to -$4463.0 in 2024.
- Per Business Quant, the three latest NXL Other Working Capital Changes figures stand at -$4463.0 (Q1 2024), -$13172.0 (Q4 2023), and -$12852.0 (Q3 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -260,000.00 |
| Sep 30, 2022 | -260,000.00 |
| Sep 30, 2022 | -260,000.00 |
| Jun 30, 2022 | 78,000.00 |
| Jun 30, 2022 | 78,000.00 |
| Jun 30, 2022 | 78,000.00 |
| Mar 31, 2022 | 52,000.00 |
| Mar 31, 2022 | 52,000.00 |
| Mar 31, 2022 | 52,000.00 |